Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

10/22) reports that last week, Biden "said...he was 'not a fan' of court-packing but has kept his options open." The New Ynrk limec (10/22, Savage, Glueck, 18.61M) reports Biden's campaign "offered few specifics about who would serve on the panel or how the campaign had settled on the idea." The Washi

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

has kept his options open." The New York Times <https://vvwvv.nytimes.com/2020/10/22/us/politics/biden-supreme-court-packing.html> (10/22, Savage, Glueck, 18.61M) reports Biden's campaign "offered few specifics about who would serve on the panel or how the campaign had settled on the idea." The Washin

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

10/22) reports that last week, Biden "said...he was 'not a fan' of court-packing but has kept his options open." The New York Times (10/22, Savage, Glueck, 18.61M) reports Biden's campaign "offered few specifics about who would serve on the panel or how the campaign had settled on the idea." The Washi